Browse publications on Google Scholar (top-right) ↗
Resume (English only)
Academic Achievements
Published over 40 first/corresponding author papers in top venues including Nature Machine Intelligence, Nature Computational Science, Nature Communications, ICML, ICLR, and NeurIPS
Leading multiple major national projects, including National Key R&D Program International Cooperation Projects and National Natural Science Foundation projects
January 2025 acceptances:
— 'PhyloTune: An efficient method to accelerate phylogenetic updates using a pretrained DNA language model' accepted at Nature Communications
— 'DivPro: diverse protein sequence design with direct structure recovery guidance' accepted at Bioinformatics
— 'Small CAG Repeat RNA Forms a Duplex Structure with Sticky Ends That Promote RNA Condensation' accepted at Journal of the American Chemical Society
— 'MM-Mixing: Multi-Modal Mixing Alignment for 3D Understanding' accepted at AAAI 2025
— 'Dual Ensembled Multiagent Q-Learning with Hypernet Regularizer' accepted at AAMAS 2025
Background
Research Professor at Hangzhou Institute of Medicine, Chinese Academy of Sciences
Associate Director of the Medical AI Center
Focuses on developing next-generation computational tools for medical AI and drug discovery
Emphasizes leveraging modern AI methods, especially large language models, to accelerate pharmaceutical R&D
Research pipeline spans processing clinical multimodal data to uncover disease mechanisms and designing targeted therapeutics
Leads a team developing intelligent drug discovery platforms with breakthroughs in core virtual screening algorithms including protein representation, pocket detection, conformational docking, molecular generation, and activity scoring